1. Home
  2. RLI vs CORT Comparison

RLI vs CORT Comparison

Compare RLI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLI Corp. (DE)

RLI

RLI Corp. (DE)

HOLD

Current Price

$65.43

Market Cap

5.9B

Sector

Finance

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$79.49

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLI
CORT
Founded
1965
1998
Country
United States
United States
Employees
1147
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
7.6B
IPO Year
1985
N/A

Fundamental Metrics

Financial Performance
Metric
RLI
CORT
Price
$65.43
$79.49
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$72.80
$139.00
AVG Volume (30 Days)
727.4K
690.9K
Earning Date
01-21-2026
11-04-2025
Dividend Yield
4.10%
N/A
EPS Growth
N/A
N/A
EPS
3.82
0.87
Revenue
$1,855,871,000.00
$741,172,000.00
Revenue This Year
N/A
$23.79
Revenue Next Year
$4.83
$40.97
P/E Ratio
$16.84
$100.74
Revenue Growth
5.16
17.92
52 Week Low
$57.75
$49.00
52 Week High
$86.05
$117.33

Technical Indicators

Market Signals
Indicator
RLI
CORT
Relative Strength Index (RSI) 63.69 49.32
Support Level $60.91 $81.31
Resistance Level $63.35 $89.00
Average True Range (ATR) 1.12 3.27
MACD 0.26 0.16
Stochastic Oscillator 92.35 29.77

Price Performance

Historical Comparison
RLI
CORT

About RLI RLI Corp. (DE)

RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: